Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs Ticagrelor in CAD Patients with CYP2C19 LOF
NCT03489863Phase 4Completed
- Sponsor
- University of Florida
- Start
- May 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of prasugrel in coronary artery disease (CAD), sponsored by University of Florida. Started May 2018; status: completed.
02
Drugs
prasugrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03489863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03489863.